Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

7,150 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Video

    Welcome: Judith Hasko (Video)

    Meet Judith Hasko who joined WilmerHale in 2024 as a partner in our Palo Alto office and co-chair of the firm's Life Sciences practice.
    United StatesFood, Drugs, Healthcare, Life Sciences
    WilmerHale
    WilmerHale
  • Article

    White House Releases More Details On President's Precision Medicine Initiative

    President Obama has revealed more details about the Precision Medicine Initiative, an interagency project aimed at revolutionizing the way health care professionals treat certain diseases.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Jones Day
    Jones Day
  • Article

    Why Study The Draft 2014 National Nanotech Initiative Strategic Plan?

    The NNI has just released its 2014 draft Strategic Plan for public comment.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Foley & Lardner LLP
    Foley & Lardner LLP
  • Video

    Will Privacy Laws Adapt? (Video)

    Jami Vibbert discusses the current application of privacy laws to healthcare and life sciences companies. Efforts to enforce those laws will show that they weren't ...
    United StatesFood, Drugs, Healthcare, Life Sciences
    Arnold & Porter
    Arnold & Porter
  • Article

    Bio/Pharma Newsletter

    The November issue of Squire Patton Boggs Bio/Pharma Beat is now available. Our monthly newsletter reports on important patent law developments in biotech,...
    United StatesIntellectual Property
    Squire Patton Boggs LLP
    Squire Patton Boggs LLP
  • Article

    Celltrion Confirms Bioequivalence For CT-P39 Against Xolair In Interim Results Of Phase 3 Study

    On April 10, 2023, Celltrion confirmed the bioequivalence of CT-P39 to treat allergic asthma and chronic urticaria, through its interim results from its global phase 3 clinical trials at 24 weeks.
    United StatesIntellectual Property
    Goodwin Procter LLP
    Goodwin Procter LLP
  • Article

    Deal On IP Rights For Biologic Drugs Under TPP Close

    According to industry and congressional sources, a deal on intellectual property rights for biologic drugs under the TPP may be in the near future.
    United StatesIntellectual Property
    Jones Day
    Jones Day
  • Article

    Genentech And Dr. Reddy's Settle BPCIA Rituximab Litigation

    Genentech, Hoffmann-La Roche, and Biogen have settled their BPCIA litigation against Dr. Reddy's Laboratories ("DRL") and Fresenius Kabi.
    United StatesIntellectual Property
    Goodwin Procter LLP
    Goodwin Procter LLP
  • Video

    Intellectual Property Partner Jason Murata In Conversation With The Hsu Untied Podcast (Video)

    Jason Murata joins Richard Hsu on the Hsu Untied podcast to discuss his background in biochemistry and biotechnology...
    United StatesIntellectual Property
    Axinn LLP
    Axinn LLP
  • Article

    Judge Sleet Concludes That Defendants Did Not Prove Invalidity Of Asserted Claim In ANDA Action

    The Court issued its findings of fact and conclusions of law pursuant to Federal Rule of Civil Procedure 52(a).
    United StatesIntellectual Property
    Fox Rothschild LLP
    Fox Rothschild LLP
  • Article

    Life Sciences Patent Trends In 2022 – Doctrine Of Equivalents

    The Federal Circuit continues to tighten the standards for written description of functional claims, particularly in the biologics realm...
    United StatesIntellectual Property
    Morrison Foerster
    Morrison Foerster
  • Article

    Podcast: Arthrex v. Smith & Nephew

    In this episode of the DeviceTalks Weekly podcast, Mike Jakes discusses why the medical device industry should be watching when the...
    United StatesIntellectual Property
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • Article

    SCOTUS Case With Implications For Attorney-Client Privilege Between CIPOs And C-Suite

    The article examines how the U.S. Supreme Court may broaden confidentiality of communications containing dual-purpose legal and business advice.
    United StatesIntellectual Property
    Herbert Smith Freehills Kramer LLP
    Herbert Smith Freehills Kramer LLP
  • Article

    Vanda Strikes Out At The Supreme Court

    Two weeks ago we discussed Vanda Pharmaceuticals' ambitious cert petition asking the Supreme Court to discontinue the "reasonable expectation of success" standard for patent...
    United StatesIntellectual Property
    Axinn LLP
    Axinn LLP
  • Article

    What High Court Will Consider In Helsinn On-Sale Bar Case

    The US Supreme Court may soon resolve an issue that has sparked much debate since the enactment of the Leahy-Smith America Invents Act—namely, whether under the AIA, an inventor's sale of an invention to a third party ...
    United StatesIntellectual Property
    WilmerHale
    WilmerHale
  • Article

    BIS And DDTC Revise Controls On Export Of Toxicological Agents And Directed Energy Weapons

    On July 28, 2016, the Department of Commerce's Bureau of Industry and Security (BIS) and the Department of State's Directorate of Defense Trade Controls issued final rules implementing revisions to U.S...
    United StatesInternational Law
    BakerHostetler
    BakerHostetler
  • Article

    U.S. Customs And Border Protection Authorized To Detain Certain Exports Of Health And Medical Materials Pursuant To FEMA Temporary Rule

    Beginning April 7, 2020, CBP is authorized to temporarily detain all shipments of five categories of personal protective equipment used in the response to and treatment of COVID-19, pursuant to a Temporary Rule issued by FEMA.
    United StatesInternational Law
    Akin
    Akin
  • Article

    Parties In Amgen v. Hospira Pegfilgrastim Litigation Stipulate To Dismissal Of All Claims

    On March 19, 2022, the parties in the Amgen Inc. v. Hospira Inc. (D. Del., No. 20-201) NEULASTA®/pegfilgrastim litigation submitted a stipulation to dismiss all claims and counterclaims...
    United StatesLitigation, Mediation & Arbitration
    Goodwin Procter LLP
    Goodwin Procter LLP
  • Article

    The Biomaterials Access Assurance Act: An Underused Tool Against Forum Shopping

    The Biomaterials Access Assurance Act was enacted in 1998 to protect biomaterial suppliers of implanted medical devices from the expenses of defending baseless civil suits.
    United StatesLitigation, Mediation & Arbitration
    Patterson Belknap Webb & Tyler LLP
    Patterson Belknap Webb & Tyler LLP
  • Podcast

    AD Nauseam: Left To Our Own Devices (Podcast)

    In this episode, hosts Amy Mudge and Daniel Kaufman discuss various health-related cases involving medical devices and FTC rulings. They delve into notable cases such as the QRay bracelet, which claimed pain relief through ionization, and the ViaTek mosquito shield band, which purported to repel mosquitoes.
    United StatesMedia, Telecoms, IT, Entertainment
    BakerHostetler
    BakerHostetler
  • Showing 201–220 of 7150 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics